Medici Therapeutics
Boston, US · Founded 2021 · Delaware corporation
Founders & leadership
DT
David ThompsonExecutive
DM
Denitsa MilanovaNamed on SEC filing
NP
Nicholas P. RestifoNamed on SEC filing
Board
MR
Matthew RabinowitzBoard director
Reported raises · per SEC filings
Form D private placements$14.8M disclosed across 1 round · 2025
▶$14.8MraisedDec 2025 · 11 investors · BiotechnologyRule 506(b)
▶$14.8MraisedDec 2025 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Denitsa MilanovaExecutive Officer, Director
- Matthew RabinowitzDirector
- David ThompsonExecutive Officer
- Nicholas P. RestifoExecutive Officer
- Offering amount
- $14.8M
- Amount sold
- $14.8M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Medici Therapeutics raised?
- Medici Therapeutics has disclosed $14.8M raised across 1 round.
- Where is Medici Therapeutics headquartered?
- Medici Therapeutics is headquartered in Boston, US.